AXA SA (CS.PA)

FR0000120628 - Common Stock

30.56  -0.38 (-1.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
122.307B
7.79%
105.176B
-14.01%
85.109B
-19.08%
87.385B
2.67%
EBITDA
YoY % growth
10.779B
37.28%
N/A
-12.21%
N/A
6.34%
10.483B
4.17%
EBIT
YoY % growth
9.909B
48.43%
10.933B
10.33%
9.491B
-13.19%
9.461B
-0.32%
Operating Margin
8.10%10.39%11.15%10.83%
EPS
YoY % growth
2.75
60.82%
3.08
12.00%
N/A
10.30%
3.64
7.02%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24
EPS
Q2Q % growth
1.80
0.70%
Revenue
Q2Q % growth
54.142B
-2.80%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
N/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth

15.24%
1.65%
Q2 2023
Q2Q % growth
1.79
8.48%
1.780.010.75%
Q4 2022
Q2Q % growth
1.43
12.60%
1.50-0.07-4.91%
Q2 2022
Q2Q % growth
1.65
11.49%
1.500.159.72%
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
47.036B
-18.71%
52.515B-5.479B-10.43%
Q2 2023
Q2Q % growth
55.7B
29.89%
57.537B-1.837B-3.19%
Q4 2022
Q2Q % growth
57.861B
-6.02%
52.48B5.381B10.25%
Q2 2022
Q2Q % growth
42.881B
-29.90%
55.225B-12.344B-22.35%
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0.48% -0.88%
RevenueN/A N/A -8.54% -10.85%